Lifestyles, Arterial Aging and Intestinal Microbiota (MIVAS III Study)
3 other identifiers
observational
1,015
1 country
2
Brief Summary
This is an observational cross-sectional study whose objective is to analyse associations between the intestinal and salivate microbiota with lifestyles (eating patterns, physical activity, tobacco and alcohol consumption), arterial aging and cognitive function. It will take place in five different research units located in Spain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2021
CompletedFirst Submitted
Initial submission to the registry
April 25, 2021
CompletedFirst Posted
Study publicly available on registry
June 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 31, 2024
December 1, 2023
2.7 years
April 25, 2021
May 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulse Wave Velocity
Measurement by SphygmoCor System (meters/seg)
1 year
Secondary Outcomes (8)
Physical Activity
1 year
Eating habits
1 year
Smoking
1 year
Drinking habits
1 year
Body composition
1 year
- +3 more secondary outcomes
Study Arms (2)
Dysbiosis microbiota
microbiota with proinflammatory pattern or dysbiosis
Normal microbiota
microbiota with antiinflammatory pattern or normal
Eligibility Criteria
Subjects aged 45 to 74 years without cardiovascular disease
You may not qualify if:
- Participants with a personal history of cardiovascular disease (ischaemic heart disease or stroke, peripheral arterial disease or Heart Failure)
- Participants with a BMI\> 40 kg / m2
- Participants diagnosed renal failure in terminal stages (GFR \<30 ml / min);
- Chronic intestinal inflammatory disease or acute inflammatory process in the past 3 months
- Oncology disease diagnosed in the last 5 years or with active treatment
- Participants who are in a terminal condition
- Consumption of antibiotics last 15 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Instituto de Investigación Biomédica de Salamancalead
- Instituto de Salud Carlos IIIcollaborator
- Castilla-León Health Servicecollaborator
Study Sites (2)
Primary Care Research Unit (APISAL)
Salamanca, 37005, Spain
Primary Care Research Unit-Valladolid
Valladolid, Spain
Related Publications (1)
Lugones-Sanchez C, Santos-Minguez S, Salvado R, Gonzalez-Sanchez S, Tamayo-Morales O, Hoya-Gonzalez A, Ramirez-Manent JI, Magallon-Botaya R, Quesada-Rico JA, Garcia-Cubillas MD, Rodriguez-Sanchez E, Gomez-Marcos MA, Benito-Sanchez R, Mira A, Hernandez-Rivas JM, Garcia-Ortiz L; MIVAS III Researchers Group. Lifestyles, arterial aging, and its relationship with the intestinal and oral microbiota (MIVAS III study): a research protocol for a cross-sectional multicenter study. Front Public Health. 2023 Jun 29;11:1164453. doi: 10.3389/fpubh.2023.1164453. eCollection 2023.
PMID: 37457284DERIVED
Biospecimen
Stool
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luis Garcia-Ortiz
Primary Care Research Unit of Salamanca (APISAL)
- PRINCIPAL INVESTIGATOR
Rita Salvado-Martins
Primary Care Research Unit
- STUDY DIRECTOR
Pedro Guimaraes-Cunha
Life and Health Sciences Research Institute in Minho University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2021
First Posted
June 14, 2021
Study Start
April 21, 2021
Primary Completion
December 30, 2023
Study Completion
December 31, 2023
Last Updated
May 31, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share